BRONCHO-VAXOM® Kinder, 3,5 mg, Kapseln, Placebo to BRONCHO-VAXOM
BV-2020/08
Approved small_molecule active
Quick answer
BRONCHO-VAXOM® Kinder, 3,5 mg, Kapseln, Placebo to BRONCHO-VAXOM for Respiratory Tract Infections with Wheezing Lower Respiratory Illness is a Approved program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Respiratory Tract Infections with Wheezing Lower Respiratory Illness
- Phase
- Approved
- Modality
- small_molecule
- Status
- active